Calcitriol and isotretinoin combined therapy for precancerous and cancerous skin lesions

Journal of Dermatological Treatment

Volumn 8, Issue 1, 1997, Pages 5-10

  Skopinska M ^a   Majewski, S ^a   Bollag, W ^b   Jablonska S ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

Author keywords

Retinoids; Skin cancers; Vitamin D

Indexed keywords

ANTI ACNE AGENT; CALCITRIOL; ISOTRETINOIN; RETINOIC ACID; VITAMIN D;

ACTINIC KERATOSIS; ADULT; AGED; ARTICLE; BASAL CELL CARCINOMA; BOWEN DISEASE; CLINICAL ARTICLE; FEMALE; HUMAN; MALE; MALIGNANT TRANSFORMATION; PRECANCER; PRIORITY JOURNAL; SKIN CANCER; SKIN DEFECT; SQUAMOUS CELL CARCINOMA;

EID: 0030947218     PISSN: 09546634     EISSN: None     Source Type: Journal    
DOI: 10.3109/09546639709160501     Document Type: Article

References (38)

1. 3 inhibits proliferation of human promyelocytic leukaemia (HL 60) cells and induces monocyte-macrophage differentiation in HL 60 and normal human bone marrow cells. Leuk Res (1983) 7: 51-5.
2. Binderup L, Bramm E, Effects of a novel vitamin D analogue MC903 on cell proliferation and differentiation in vitro and on calcium metabolism in vivo. Biochem Pharmacol (1988) 37: 889-95.
3. 3 on the morphologic and biochemical differentiation of cultured human epidermal keratinocytes growth in serum-free conditions. J Invest Dermatol (1986) 86: 706-16.
4. Rains V, Cunningham D, Soukop M, Alfacalcidol is a nontoxic, effective treatment of follicular small-cleaved cell lymphoma. Br J Cancer (1991) 63: 463-5.
5. 3 metabolites. Cancer Res (1983) 43: 4443-7.
6. 3. Cancer Res (1987) 47: 21-5
7. Bollag W, New retinoids with potential use in humans. In: Saurat JH (ed) Retinoids: new trends in research and therapy. Retinoid Symposium: Birkhäuser Verlag: Basel, 1985, pp 274-88.
8. Jetten AM, Kim JS, Sacks PC et al, Inhibition of growth and squamous cell differentiation markers in cultured human head and neck squamous carcinoma cells by β-all-trans retinoic acid. Int J Cancer (1990) 45: 195-202.
9. Bollag W, Hartmann HR, Prevention and therapy of cancer with retinoids in animals and man. Cancer Surv (1983) 2: 293-314.
10. Lippman SM, Kessler JF, Meyskens FL Jr, Retinoids as preventive and therapeutic anticancer agents. II. Cancer Treat Rep (1987) 71: 493-515.
11. Huang ME, Ye YC, Chen SR et al, Use of all-trans-retinoic acid in the treatment of acute promyelocytic leukemia. Blood (1988) 72: 567-72.
12. Majewski S, Skopinska M, Bollage W et al, Combination of isotretinoin and calcitriol for precancerous and cancerous skin lesions. Lancet (1994) 344: 1510-11.
13. Giguere V, Yang N, Segui P et al, Identification of a new class of steroid hormone receptors. Nature (1988) 331: 91-4.
14. Evans RM, The steroid and thyroid hormone receptor superfamily. Science (1988) 240: 889-95.
15. Kliewer SA, Umesono K, Mangelsdorf DJ et al, Retinoid X receptor interacts with nuclear receptors in retinoic acid, thyroid hormone and vitamin D signalling. Nature (1992) 355: 446-9.
16. Mangelsdorf DJ, Borgmeyer U, Heyman RA et al, Characterisation of three RXRs genes that mediate the action of 9-cis retinoic acid. Genes Dev (1992) 6: 329-44.
17. 3 receptors. Cell (1991) 65: 1255-66.
18. Schrader M, Bendik I, Becker-Andre M et al, Interaction between retinoic acid and vitamin D signalling pathways. J Biol Chem (1993) 268: 17830-6.
19. Reichel H, Koeffler HP, Norman AW, The role of vitamin D endocrine system in health and disease. N Engl J Med (1989) 320: 980-91.
20. Elder JT, Fisher GJ, Zhang QY et al, Retinoic acid receptor gene expression in human skin. J Invest Dermatol (1991) 96: 425-33.
21. 3 receptors in normal and psoriatic skin. J Invest Dermatol (1991) 97: 230-6.
22. 3 on the differentiation of the human monocytic cell line U937. Leuk Res (1991) 15: 1145-52.
23. Dore BT, Uskokovic MR, Momparler RL, Induction of differentiation in HL-60 myeloid leukaemia cells by retinoic acid and vitamin D analogs. Proc Am Assoc Cancer Res (1992) 33: 2640.
24. 3 analogs efficiently promote growth inhibition and differentiation of myelomonocytic leukemia cell lines. J Pharmacol Exp Ther (1994) 271: 193-9.
25. French LE, Ramelet AA, Saurat J-H, Remission of cutaneous T-cell lymphoma with combined calcitriol and acitretin. Lancet (1994) 344: 686-7.
26. Alirezai M, Dupuy P, Amblard P et al, Clinical evaluation of topical isotretinoin in the treatment of actinic keratoses. J Am Acad Dermatol (1994) 30: 447-51.
27. Bollag W, Ott F, Retinoic acid: topical treatment of senile or actinic keratoses and basal cell carcinomas. Agents Actions (1970) 1: 172-5.
28. Robinson TA, Kligman AM, Treatment of solar keratoses of the extremities with retinoic acid and 5-fluorouracil. Br J Dermatol (1975) 92: 703-6.
29. Peck LG, Topical tretinoin in actinic keratosis and basal cell carcinoma. J Am Acad Dermatol (1986) 15: 829-35.
30. Marth C, Daxenbichler G, Dapunt O, Synergistic antiproliferative effect of human recombinant interferons and retinoic acid in cultured breast cancer cells. J Natl Cancer Just (1986) 77: 1197-202.
31. Frey JR, Peck R, Bollag W, Antiproliferative activity of retinoids, interferon a and their combination in five human transformed cell lines. Cancer Lett (1991) 57: 223-7.
32. Gullberg U, Nilsson E, Einhorn S et al, Combinations of interferon-γ and retinoic acid or 1α,25-dihydroxycholecalciferol induce differentiation of the human monoblast leukemia cell line U-937. Exp Hematol (1985) 13: 675-9.
33. 3: preliminary evidence suggesting that interferon induces expression of the vitamin receptor. Haematologica (1991) 76: 467-71.
34. 3 and their combination. Cancer Lett (1993) 75: 35-9.
35. 3 and their combination inhibit angiogenesis induced by non-HPV-harboring tumor cell lines: RARα mediates the antiangiogeneic effect of retinoids. Cancer Lett (1995) 89: 117-24.
36. Lippman SM, Parkinson DR, Itri LM et al, 13-cis-retinoic acid and interferon α-2a: effective combination therapy for advanced squamous cell carcinoma of the skin. J Natl Cancer Inst (1992) 84: 235-41.
37. Nguyen T, De Forni M, Armand JP et al, Remission complete d'un carcinome spinocellulaire cutane traite par l'association interferon alpha 2a-isotretinoine apres echec des traitments habituels. Ann Dermatol Venereol (1993) 120: 827-9.
38. Kraemer KH, DiGiovanna JJ, Peck GL, Chemoprevention of skin cancer in xeroderma pigmentosum. J Dermatol (1992) 19: 715-18.